⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22038805 | 1.00 | — | — | |
| SCHEMBL23813720 | 0.94 | — | — | |
| SCHEMBL22057295 | 0.92 | — | — | |
| SCHEMBL28455474 | 0.90 | — | — | |
| SCHEMBL22057294 | 0.89 | — | — | |
| SCHEMBL22180988 | 0.89 | — | — | |
| SCHEMBL20801357 | 0.89 | — | — | |
| SCHEMBL20801353 | 0.89 | — | — | |
| SCHEMBL20801483 | 0.88 | NAAA (0.34) | — | |
| SCHEMBL18947925 | 0.87 | PRKCA (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793613-B1 | IMMUNOCONJUGATES | BOLT BIOTHERAPEUTICS INC (US) | 2025-01-01 | — | — | EP | disclosed |
| US-20210154316-A1 | Immunoconjugates | BOLT BIOTHERAPEUTICS, INC. (US) | 2021-05-27 | — | — | US | disclosed |
| EP-3793613-A1 | IMMUNOCONJUGATES | Bolt Biotherapeutics, Inc. (US) | 2021-03-24 | — | — | EP | disclosed |
| US-20200386748-A1 | COMPOSITIONS AND METHODS FOR ANALYTE DETECTION USING BIOLUMINESCENCE | PROMEGA CORPORATION | 2020-12-10 | — | — | US | disclosed |
| WO-2020210658-A1 | COMPOSITIONS AND METHODS FOR ANALYTE DETECTION USING BIOLUMINESCENCE | PROMEGA CORPORATION (US) | 2020-10-15 | — | — | WO | disclosed |